Cargando…

COVID-19 Vaccine Development in a Quadruple Helix Innovation System: Uncovering the Preferences of the Fourth Helix in the UAE

Successful development and uptake of vaccine technology in a Quadruple Helix Innovative health or economic system requires a clear understanding of society’s preferences as the fourth helix. With significant financial commitments to find a safe and effective COVID-19 vaccine still ongoing, this stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Niankara, Ibrahim, Muqattash, Riham, Niankara, Aminata, Traoret, Rachidatou I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: the authors. Published by Elsevier Ltd 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906489/
http://dx.doi.org/10.3390/joitmc6040132
_version_ 1784883990278176768
author Niankara, Ibrahim
Muqattash, Riham
Niankara, Aminata
Traoret, Rachidatou I.
author_facet Niankara, Ibrahim
Muqattash, Riham
Niankara, Aminata
Traoret, Rachidatou I.
author_sort Niankara, Ibrahim
collection PubMed
description Successful development and uptake of vaccine technology in a Quadruple Helix Innovative health or economic system requires a clear understanding of society’s preferences as the fourth helix. With significant financial commitments to find a safe and effective COVID-19 vaccine still ongoing, this study introduces a random utility theoretic behavioral health model to analyze individuals’ prospective demand for the vaccine in the United Arab Emirates (UAE). To this end, we use a cross-sectional sample of stated vaccine preferences data collected online using the snowball method, between 4 July and 4 August 2020, gathering 1109 responses across all seven Emirates of the UAE. We found that in addition to socio-economic and demographic influences, the factors affecting individuals’ preferences for the prospective COVID-19 vaccine in the UAE include those put forth by the WHO’s SAGE group on immunization. Though the estimated indirect cost, in the form of expected marginal utility of time spent to get the vaccine is not statistically significant, the expected marginal utility of every dirham spent to get the vaccine is −1.76 AED and significant, suggesting a significant expected dis-utility from COVID-19 vaccine seeking/payment by the average person. Our findings also highlight significant perceived financial, temporal and spatial barriers to COVID-19 vaccine uptake in the UAE. Therefore, a set of measures are suggested to help mitigate the adverse effects of these three constraints. Our study thus contributes methodologically to the literature on vaccine demand, hesitancy and development. It also contributes to the nascent empirical evidence on the novel coronavirus disease, by providing significant insights for evidence based policy making that should increase the effectiveness of any prospective COVID-19 vaccination program in the UAE.
format Online
Article
Text
id pubmed-9906489
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher the authors. Published by Elsevier Ltd
record_format MEDLINE/PubMed
spelling pubmed-99064892023-02-08 COVID-19 Vaccine Development in a Quadruple Helix Innovation System: Uncovering the Preferences of the Fourth Helix in the UAE Niankara, Ibrahim Muqattash, Riham Niankara, Aminata Traoret, Rachidatou I. Journal of Open Innovation: Technology, Market, and Complexity Article Successful development and uptake of vaccine technology in a Quadruple Helix Innovative health or economic system requires a clear understanding of society’s preferences as the fourth helix. With significant financial commitments to find a safe and effective COVID-19 vaccine still ongoing, this study introduces a random utility theoretic behavioral health model to analyze individuals’ prospective demand for the vaccine in the United Arab Emirates (UAE). To this end, we use a cross-sectional sample of stated vaccine preferences data collected online using the snowball method, between 4 July and 4 August 2020, gathering 1109 responses across all seven Emirates of the UAE. We found that in addition to socio-economic and demographic influences, the factors affecting individuals’ preferences for the prospective COVID-19 vaccine in the UAE include those put forth by the WHO’s SAGE group on immunization. Though the estimated indirect cost, in the form of expected marginal utility of time spent to get the vaccine is not statistically significant, the expected marginal utility of every dirham spent to get the vaccine is −1.76 AED and significant, suggesting a significant expected dis-utility from COVID-19 vaccine seeking/payment by the average person. Our findings also highlight significant perceived financial, temporal and spatial barriers to COVID-19 vaccine uptake in the UAE. Therefore, a set of measures are suggested to help mitigate the adverse effects of these three constraints. Our study thus contributes methodologically to the literature on vaccine demand, hesitancy and development. It also contributes to the nascent empirical evidence on the novel coronavirus disease, by providing significant insights for evidence based policy making that should increase the effectiveness of any prospective COVID-19 vaccination program in the UAE. the authors. Published by Elsevier Ltd 2020-12 2022-12-31 /pmc/articles/PMC9906489/ http://dx.doi.org/10.3390/joitmc6040132 Text en © 2020 the authors. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Niankara, Ibrahim
Muqattash, Riham
Niankara, Aminata
Traoret, Rachidatou I.
COVID-19 Vaccine Development in a Quadruple Helix Innovation System: Uncovering the Preferences of the Fourth Helix in the UAE
title COVID-19 Vaccine Development in a Quadruple Helix Innovation System: Uncovering the Preferences of the Fourth Helix in the UAE
title_full COVID-19 Vaccine Development in a Quadruple Helix Innovation System: Uncovering the Preferences of the Fourth Helix in the UAE
title_fullStr COVID-19 Vaccine Development in a Quadruple Helix Innovation System: Uncovering the Preferences of the Fourth Helix in the UAE
title_full_unstemmed COVID-19 Vaccine Development in a Quadruple Helix Innovation System: Uncovering the Preferences of the Fourth Helix in the UAE
title_short COVID-19 Vaccine Development in a Quadruple Helix Innovation System: Uncovering the Preferences of the Fourth Helix in the UAE
title_sort covid-19 vaccine development in a quadruple helix innovation system: uncovering the preferences of the fourth helix in the uae
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906489/
http://dx.doi.org/10.3390/joitmc6040132
work_keys_str_mv AT niankaraibrahim covid19vaccinedevelopmentinaquadruplehelixinnovationsystemuncoveringthepreferencesofthefourthhelixintheuae
AT muqattashriham covid19vaccinedevelopmentinaquadruplehelixinnovationsystemuncoveringthepreferencesofthefourthhelixintheuae
AT niankaraaminata covid19vaccinedevelopmentinaquadruplehelixinnovationsystemuncoveringthepreferencesofthefourthhelixintheuae
AT traoretrachidatoui covid19vaccinedevelopmentinaquadruplehelixinnovationsystemuncoveringthepreferencesofthefourthhelixintheuae